Who is sponsoring NCT02382341?

NCT02382341 is sponsored by Smith & Nephew, Inc..

What drugs are being tested in NCT02382341?

Interventions in NCT02382341: BIOSURE™ HEALICOIL™ PK Interference Screw.

What condition does NCT02382341 study?

NCT02382341 studies Deficiency of Anterior Cruciate Ligament.

Is NCT02382341 still recruiting?

NCT02382341 is currently completed. Last updated 7 September 2020.

Last reviewed 2020-09-07 · How we verify

NCT02382341

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

BIOSURE™ HEALICOIL™ PK Bone In-growth Study

Completed Last updated 7 September 2020

What this trial tests

trial testing BIOSURE™ HEALICOIL™ PK Interference Screw in Deficiency of Anterior Cruciate Ligament in 12 participants. Completed in 4 January 2017.

Timeline

12 September 2014

Primary endpoint
4 January 2017

4 January 2017

Quick facts

Lead sponsor	Smith & Nephew, Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	12
Start date	12 September 2014
Primary completion	4 January 2017
Estimated completion	4 January 2017

Drugs / interventions tested

BIOSURE™ HEALICOIL™ PK Interference Screw

Conditions studied

Deficiency of Anterior Cruciate Ligament — all drugs for Deficiency of Anterior Cruciate Ligament →

Sponsor

Smith & Nephew, Inc. — full company profile →

Who can join

Adults 18 to 50, any sex, with Deficiency of Anterior Cruciate Ligament. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study seeks to document the bone in-growth into the BIOSURE™ HEALICOIL PK screw as measured by CT scans. Patients' improvement in pain and function will also be followed through various outcome measures.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Bone ingrowth into open architecture PEEK interference screw after ACL reconstruction.
Lind M, Nielsen T, Sørensen OG, Mygind-Klavsen B, et al · · 2020 · cited 5× · PMID 32948982 · DOI 10.1186/s40634-020-00285-z

Verify or expand the search:

Other Smith & Nephew, Inc. trials

Trials by the same sponsor.

NCT07025304 — Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate · NA · recruiting
NCT06916728 — A Post Approval Multicenter 10 Year Follow-up Observational Trial of Marketed Product - MP01 vs. Surgical Standard of Ca · enrolling by invitation
NCT06831448 — Human Participant Study of a Prototype Multilayer Foam Dressing on Intact Skin. · NA · completed
NCT06700850 — Human Participant Study of Prototype Non-medicated Multilayer Foam Dressings on Intact Skin · NA · completed
NCT06306716 — A Clinical Study on New Negative Pressure Wound Therapy Dressing in the Management of Chronic & Acute Wounds · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02382341 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Smith & Nephew, Inc.
Last refreshed: 7 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02382341.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing